Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample.

Mullen MT, Kasner SE, Kallan MJ, Kleindorfer DO, Albright KC, Carr BG.

J Am Heart Assoc. 2013 Mar 26;2(2):e000071. doi: 10.1161/JAHA.112.000071.

2.

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.

Aparicio HJ, Carr BG, Kasner SE, Kallan MJ, Albright KC, Kleindorfer DO, Mullen MT.

J Am Heart Assoc. 2015 Oct 14;4(10):e001877. doi: 10.1161/JAHA.115.001877.

3.

Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.

Rajamani K, Millis S, Watson S, Mada F, Salowich-Palm L, Hinton S, Chaturvedi S.

J Stroke Cerebrovasc Dis. 2013 Jan;22(1):49-54. doi: 10.1016/j.jstrokecerebrovasdis.2011.06.003.

PMID:
21852156
4.

Rates of Adverse Events and Outcomes among Stroke Patients Admitted to Primary Stroke Centers.

Chaudhry SA, Afzal MR, Chaudhry BZ, Zafar TT, Safdar A, Kassab MY, Hussain SI, Qureshi AI.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1960-5. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.045. Epub 2016 May 18.

PMID:
27209089
5.

Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample.

Boehme AK, Carr BG, Kasner SE, Albright KC, Kallan MJ, Elkind MSV, Branas CC, Mullen MT.

Front Neurol. 2017 Sep 27;8:500. doi: 10.3389/fneur.2017.00500. eCollection 2017.

6.

Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers.

Lichtman JH, Jones SB, Wang Y, Watanabe E, Leifheit-Limson E, Goldstein LB.

Neurology. 2011 Jun 7;76(23):1976-82. doi: 10.1212/WNL.0b013e31821e54f3. Epub 2011 May 4.

7.

Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization.

Man S, Cox M, Patel P, Smith EE, Reeves MJ, Saver JL, Bhatt DL, Xian Y, Schwamm LH, Fonarow GC.

Stroke. 2017 Feb;48(2):412-419. doi: 10.1161/STROKEAHA.116.014426. Epub 2016 Dec 22.

PMID:
28008094
8.

Impact of Stroke Center Certification on Mortality After Ischemic Stroke: The Medicare Cohort From 2009 to 2013.

Man S, Schold JD, Uchino K.

Stroke. 2017 Sep;48(9):2527-2533. doi: 10.1161/STROKEAHA.116.016473. Epub 2017 Jul 26.

PMID:
28747463
9.

Primary Stroke Center Hospitalization for Elderly Patients With Stroke: Implications for Case Fatality and Travel Times.

Bekelis K, Marth NJ, Wong K, Zhou W, Birkmeyer JD, Skinner J.

JAMA Intern Med. 2016 Sep 1;176(9):1361-8. doi: 10.1001/jamainternmed.2016.3919.

10.

Intravenous thrombolysis for stroke increases over time at primary stroke centers.

Prabhakaran S, McNulty M, O'Neill K, Ouyang B.

Stroke. 2012 Mar;43(3):875-7. doi: 10.1161/STROKEAHA.111.640060. Epub 2011 Dec 1.

11.

Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients.

Nasr DM, Biller J, Rabinstein AA.

Pediatr Neurol. 2014 Nov;51(5):624-31. doi: 10.1016/j.pediatrneurol.2014.07.030. Epub 2014 Jul 30.

PMID:
25194722
12.

Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.

Lawson TR, Brown IE, Westerkam DL, Blackhurst DW, Sternberg S, Leacock R, Nathaniel TI.

Restor Neurol Neurosci. 2015;33(3):301-8. doi: 10.3233/RNN-140480.

PMID:
25698111
13.

The impact of lesion side on acute stroke treatment.

Di Legge S, Fang J, Saposnik G, Hachinski V.

Neurology. 2005 Jul 12;65(1):81-6.

PMID:
16009890
14.

Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.

Iguchi Y, Kimura K, Shibazaki K, Iwanaga T.

J Neurol Sci. 2009 Apr 15;279(1-2):66-9. doi: 10.1016/j.jns.2008.12.016. Epub 2009 Jan 30.

PMID:
19185882
15.

US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.

Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R.

Stroke. 2009 Nov;40(11):3580-4. doi: 10.1161/STROKEAHA.109.554626. Epub 2009 Oct 1.

16.

A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.

Yan X, Hu HT, Liu S, Sun YH, Gao X.

Neurol Res. 2015 Apr;37(4):352-8. doi: 10.1179/1743132814Y.0000000447. Epub 2014 Oct 8.

PMID:
25297471
17.

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.

Mione G, Ducrocq X, Thilly N, Lacour JC, Vespignani H, Richard S.

Geriatr Gerontol Int. 2016 Jul;16(7):843-9. doi: 10.1111/ggi.12565. Epub 2015 Aug 5.

PMID:
26245693
18.

National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.

Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP.

Stroke. 2008 Mar;39(3):924-8. doi: 10.1161/STROKEAHA.107.490375. Epub 2008 Jan 31.

19.

Pennsylvania comprehensive stroke center collaborative: Statement on the recently updated IV rt-PA prescriber information for acute ischemic stroke.

Daou B, Deprince M, D'Ambrosio R, Tjoumakaris S, Rosenwasser RH, Ackerman DJ, Bell R, Tzeng DL, Ghobrial M, Fernandez A, Shah Q, Gzesh DJ, Murphy D, Castaldo JE, Mathiesen C, Pineda MC, Jabbour P.

Clin Neurol Neurosurg. 2015 Dec;139:264-8. doi: 10.1016/j.clineuro.2015.10.010. Epub 2015 Oct 21.

PMID:
26539671
20.

Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.

Xian Y, Federspiel JJ, Hernandez AF, Laskowitz DT, Schwamm LH, Bhatt DL, Smith EE, Fonarow GC, Peterson ED.

Circulation. 2017 Mar 14;135(11):1024-1035. doi: 10.1161/CIRCULATIONAHA.116.023940. Epub 2017 Jan 24.

PMID:
28119380

Supplemental Content

Support Center